Grantham, Mayo, Van Otterloo & Co (GMO)’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
53,059
+222
+0.4% +$7.29K ﹤0.01% 486
2026
Q1
$1.97M Buy
52,837
+333
+0.6% +$13.7K 0.01% 434
2025
Q4
$2.46M Sell
52,504
-957
-2% -$41.4K 0.01% 396
2025
Q3
$2.24M Sell
53,461
-34,691
-39% -$1.52M 0.01% 366
2025
Q2
$3.88M Sell
88,152
-10,520
-11% -$476K 0.01% 319
2025
Q1
$4.97M Buy
98,672
+80,286
+437% +$3.98M 0.02% 302
2024
Q4
$790K Buy
+18,386
New +$776K ﹤0.01% 468
2023
Q1
Sell
-156,839
Closed -$7.26M 727
2022
Q4
$7.26M Buy
156,839
+16,112
+11% +$733K 0.04% 286
2022
Q3
$6.16M Buy
+140,727
New +$6.47M 0.04% 305
2022
Q1
Sell
-37,810
Closed -$2.01M 724
2021
Q4
$2.01M Sell
37,810
-13,964
-27% -$703K 0.01% 462
2021
Q3
$2.46M Buy
+51,774
New +$2.57M 0.01% 428
2020
Q2
Sell
-32,278
Closed -$943K 784
2020
Q1
$943K Buy
32,278
+3,500
+12% +$137K 0.01% 505
2019
Q4
$1.21M Buy
28,778
+2,900
+11% +$116K 0.01% 489
2019
Q3
$1M Buy
+25,878
New +$1.03M 0.01% 545

Other funds holding G

Grantham, Mayo, Van Otterloo & Co (GMO)'s G Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Genpact (G) stake by 0.42% in Q2 2026, buying an estimated $7.29K and bringing the position to 53,059 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in G in Q3 2019 and has held it in 14 quarters since. The position peaked at $7.26M in Q4 2022. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 53,059 shares of Genpact worth $1.46M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 222 Genpact shares in Q2 2026, an estimated $7.29K.
  • Genpact made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #486 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Genpact in Q3 2019 and has held it in 14 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Genpact position peaked at $7.26M in Q4 2022.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.